115 related articles for article (PubMed ID: 17580228)
1. Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis.
Fang B; Song Y; Zhao RC; Han Q; Lin Q
Transplant Proc; 2007 Jun; 39(5):1710-3. PubMed ID: 17580228
[TBL] [Abstract][Full Text] [Related]
2. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease.
Fang B; Song Y; Liao L; Zhang Y; Zhao RC
Transplant Proc; 2007 Dec; 39(10):3358-62. PubMed ID: 18089385
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells.
Fang B; Song YP; Liao LM; Han Q; Zhao RC
Bone Marrow Transplant; 2006 Sep; 38(5):389-90. PubMed ID: 16878145
[No Abstract] [Full Text] [Related]
4. Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children.
Fang B; Song Y; Lin Q; Zhang Y; Cao Y; Zhao RC; Ma Y
Pediatr Transplant; 2007 Nov; 11(7):814-7. PubMed ID: 17910665
[TBL] [Abstract][Full Text] [Related]
5. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
6. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
Wollina U; Sayer HG; Wollina K; Graefe T
J Dermatol; 2001 Dec; 28(12):734-6. PubMed ID: 11804070
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
9. [Mesenchymal stem cells as salvage therapy for steroid resistant acute graft-versus-host disease following haploidentical hematopoietic stem cell transplantation].
Xue M; Wang ZD; Dong L
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):878-80. PubMed ID: 22339970
[No Abstract] [Full Text] [Related]
10. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
11. Severe eosinophilia as a manifestation of acute graft-versus-host disease.
Paralkar VR; Goradia A; Luger SM; Loren AW
Oncology; 2008; 75(3-4):134-6. PubMed ID: 18791329
[TBL] [Abstract][Full Text] [Related]
12. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
13. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.
Bloor AJ; Thomson K; Chowdhry N; Verfuerth S; Ings SJ; Chakraverty R; Linch DC; Goldstone AH; Peggs KS; Mackinnon S
Biol Blood Marrow Transplant; 2008 Jan; 14(1):50-8. PubMed ID: 18158961
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
16. Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.
Helbig G; Krzemień S; Francuz T; Wojnar J; Hołowiecki J
Med Sci Monit; 2008 Nov; 14(11):CR584-8. PubMed ID: 18971876
[TBL] [Abstract][Full Text] [Related]
17. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
18. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
[TBL] [Abstract][Full Text] [Related]
19. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
[TBL] [Abstract][Full Text] [Related]
20. Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.
Carnevale-Schianca F; Martin P; Sullivan K; Flowers M; Gooley T; Anasetti C; Deeg J; Furlong T; McSweeney P; Storb R; Nash RA
Biol Blood Marrow Transplant; 2000; 6(6):613-20. PubMed ID: 11128811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
